Dose-Dependent Effects in Plasma Oncotherapy: Critical In Vivo Immune Responses Missed by In Vitro Studies
Biomolecules · 2023
DOI: 10.3390/biom13040707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Yuanyuan He und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China. Hauptthemen laut MEDLINE: B7-H1 Antigen, Colonic Neoplasms, Plasma Gases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R&D plan of Anhui Province, Fundamental Research Funds for the Central Universities, Plasma Applied Technology Joint Laboratory Development Funding.
Abstract (Originalsprache)
Cold atmospheric plasma (CAP) generates abundant reactive oxygen and nitrogen species (ROS and RNS, respectively) which can induce apoptosis, necrosis, and other biological responses in tumor cells. However, the frequently observed different biological responses to in vitro and in vivo CAP treatments remain poorly understood. Here, we reveal and explain plasma-generated ROS/RNS doses and immune system-related responses in a focused case study of the interactions of CAP with colon cancer cells in vitro and with the corresponding tumor in vivo. Plasma controls the biological activities of MC38 murine colon cancer cells and the involved tumor-infiltrating lymphocytes (TILs). In vitro CAP treatment causes necrosis and apoptosis in MC38 cells, which is dependent on the generated doses of intracellular and extracellular ROS/RNS. However, in vivo CAP treatment for 14 days decreases the proportion and number of tumor-infiltrating CD8+T cells while increasing PD-L1 and PD-1 expression in the tumors and the TILs, which promotes tumor growth in the studied C57BL/6 mice. Furthermore, the ROS/RNS levels in the tumor interstitial fluid of the CAP-treated mice are significantly lower than those in the MC38 cell culture supernatant. The results indicate that low doses of ROS/RNS derived from in vivo CAP treatment may activate the PD-1/PD-L1 signaling pathway in the tumor microenvironment and lead to the undesired tumor immune escape. Collectively, these results suggest the crucial role of the effect of doses of plasma-generated ROS and RNS, which are generally different in in vitro and in vivo treatments, and also suggest that appropriate dose adjustments are required upon translation to real-world plasma oncotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China.
- Department of Geriatrics, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei 230001, China.
- Department of Medical Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei 230001, China.
- Joint Laboratory of Plasma Application Technology, Institute of Advanced Technology, University of Science and Technology of China, Hefei 230026, China.
- Department of Orthopedics, School of Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China.
- Department of Physics, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong 999077, China.
ORCID-Profile: Paul K Chu
Förderung
- Key R&D plan of Anhui Province
- Fundamental Research Funds for the Central Universities
- Plasma Applied Technology Joint Laboratory Development Funding
- Hong Kong PDFS—RGC Postdoctoral Fellowship Scheme
- Hong Kong HMRF (Health and Medical Research Fund)
Zitieren
APA
He, Y., Gong, F., Jin, T., Liu, Q., Fang, H., Chen, Y., Wang, G., Chu, P. K., Wu, Z., & Ostrikov, K. K. (2023). Dose-Dependent Effects in Plasma Oncotherapy: Critical In Vivo Immune Responses Missed by In Vitro Studies. Biomolecules. https://doi.org/10.3390/biom13040707
Vancouver
He Y, Gong F, Jin T, Liu Q, Fang H, Chen Y, et al. Dose-Dependent Effects in Plasma Oncotherapy: Critical In Vivo Immune Responses Missed by In Vitro Studies. Biomolecules. 2023. doi:10.3390/biom13040707
BibTeX
@article{He2023,
author = {He, Yuanyuan and Gong, Fanwu and Jin, Tao and Liu, Qi and Fang, Haopeng and Chen, Yan and Wang, Guomin and Chu, Paul K and Wu, Zhengwei and Ostrikov, Kostya Ken},
title = {Dose-Dependent Effects in Plasma Oncotherapy: Critical In Vivo Immune Responses Missed by In Vitro Studies},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13040707}
}
EUVIMED